Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Buy Ariana Resources (AAU) by Tom Winnifrith in Hot Stock Rockets
- Long Term Buy SSE (SSE) by Tom Rodgers in The Motley Fool
- Hold ITV (ITV) by Edward Sheldon in The Motley Fool
- Buy DCC (DCC) by Manika Premsingh in The Motley Fool
- Buy Rentokil Initial (RTO) by Manika Premsingh in The Motley Fool
- Sell DotDigital Group (DOTD) by Steve Moore in ShareProphets
- Avoid Accesso Technology Group (ACSO) by Steve Moore in ShareProphets
- Long Term Buy Burberry Group (BRBY) by Peter Stephens in The Motley Fool
- Buy Primary Health Properties (PHP) by Harvey Jones in The Motley Fool
- Buy Bunzl (BNZL) by Rupert Hargreaves in The Motley Fool
- Long Term Buy HSBC Holdings (HSBA) by Rupert Hargreaves in The Motley Fool
- Buy Yourgene Health (YGEN) by Hot Stock Rockets in Five Free Share Tips
- Long Term Buy Anglo American (AAL) by Harvey Jones in The Motley Fool
- Long Term Buy Rio Tinto (RIO) by Harvey Jones in The Motley Fool
- Buy Sainsbury (J) (SBRY) by Kirsteen Mackay in The Motley Fool
- Buy Hargreaves Lansdown (HL.) by Jonathan Smith in The Motley Fool
- Sell Royal Bank of Scotland Group (RBS) by Royston Wild in The Motley Fool
- Buy BT Group (BT.A) by Jonathan Smith in The Motley Fool
- Buy Yourgene Health (YGEN) by Hot Stock Rockets in ShareProphets
- Hold Lloyds Banking Group (LLOY) by Malcolm Stacey in ShareProphets
Dechra Pharmaceuticals (DPH)
Health Care Sector
-
Latest quote
2,626.00p (mid)
-
Current Change (%)
0.92%
-
Price
Bid: 2,640.00p
Offer: 2,642.00p
-
Today
High: 2,650.00p
Low: 2,606.00p
-
This year
High: 3,036.00p
Low: 2,014.00p
-
Information
Volume: 313,746
Market Cap: £2678.52M
NOTE: This is based on 34 open tips for this company
Dechra Pharmaceuticals Overview
Dechra Pharmaceuticals, founded in 1997 following a management buy-out from Lloyds Chemists, develops prescription only veterinary medicines for dogs, cats and horses. Most of its projects involve adapting treatments, currently used by humans, for the animal market. Expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. It listed in London in 2000.Dechra Pharmaceuticals RNS Feed
| Title | Release date |
|---|---|
| Holding(s) in Company | 15:42 - October 2, 2019 |
| Total Voting Rights | 09:49 - September 30, 2019 |
| Director/PDMR Shareholding | 16:50 - September 23, 2019 |
| Director/PDMR Shareholdings | 09:32 - September 18, 2019 |
| Annual Financial Report | 10:03 - September 17, 2019 |
| Block listing Interim Review | 14:15 - September 16, 2019 |
| Opening of its solar power plant in Croatia & CMD | 10:34 - September 11, 2019 |
| Director/PDMR Shareholding | 15:45 - September 6, 2019 |
| Availability of the 2019 Annual Report | 13:32 - September 4, 2019 |
| Audited preliminary results - year ended 30.6.19 | 07:00 - September 2, 2019 |
| Additional Listing | 12:55 - August 30, 2019 |
| Acquisition of Ampharmco LLC, USA | 07:00 - August 29, 2019 |
| LICENSING AGREEMENT FOR SIGNIFICANT NOVEL PRODUCT | 07:30 - August 2, 2019 |
| Trading Update & Notice of Results | 07:00 - July 9, 2019 |
| Holding(s) in Company | 14:38 - July 5, 2019 |
